Form EFFECT Esperion Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 15, 2026 |
| Accession Number: | 0001104659-26-083007 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Quaint Oak Bancorp, Inc. Declares Quarterly Cash Dividend
- ELEKTROS Advances Long-Term EV Charging Strategy as Industry Momentum Continues to Build
- ELEKTROS Reinforces Strategic EV Charging Vision Amid Expanding Global Infrastructure Demand
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
